Related Experiment Video
Updated: Jul 15, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Von Willebrand disease - phenotype versus genotype: deficiency versus disease
1Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada. lillicrap@cliff.path.queensu.ca
Insights
Von Willebrand disease (VWD) has three main types based on von Willebrand factor (VWF) levels and function. Genetic studies reveal complex molecular causes for VWD subtypes, particularly type 1.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Von Willebrand disease (VWD) is categorized into three main subtypes: type 1 (partial quantitative deficiency), type 2 (qualitative defects including 2A, 2B, 2M, 2N), and type 3 (near-complete deficiency of von Willebrand factor (VWF)).
- Subtypes of type 2 VWD involve distinct defects: 2A (low-molecular-weight VWF), 2B (increased platelet binding), 2M (impaired adhesion despite normal VWF size), and 2N (reduced factor VIII binding).
- Genetic underpinnings for VWD subtypes are increasingly understood, with type 3 linked to null mutations and type 2N to specific missense mutations affecting factor VIII binding.
Purpose of the Study:
- To explore the association between specific genetic variants of von Willebrand factor (VWF) and the resulting disease phenotype in Von Willebrand disease (VWD).
- To characterize the molecular pathogenesis of type 1 VWD, highlighting the diverse genetic changes involved.
- To investigate the complexity of genetic factors contributing to type 1 VWD, including potential involvement of genes beyond VWF.
Main Methods:
- Classification of VWD into subtypes based on quantitative and qualitative von Willebrand factor (VWF) defects.
- Analysis of genetic variants, including missense, splice site, and transcriptional mutations, in patients with Von Willebrand disease (VWD).
- Examination of VWF gene sequences and assessment for multiple variant sequences or absence of detectable changes in affected individuals.
Main Results:
- Type 3 VWD is associated with mutations leading to a null phenotype, while type 2N VWD results from recessive missense mutations impairing factor VIII binding.
- Molecular characterization of type 1 VWD reveals a broad spectrum of genetic alterations, with patients often heterozygous for various mutations.
- In some type 1 VWD cases, multiple variant VWF sequences were identified, and in a significant number, no VWF gene changes were detected, suggesting other genetic factors may be involved.
Conclusions:
- The genetic basis for Von Willebrand disease (VWD) subtypes is diverse, with specific mutations correlating with distinct phenotypes.
- The molecular pathogenesis of type 1 VWD is complex, involving a wide range of genetic changes at the VWF locus.
- The genetic architecture of type 1 VWD likely extends beyond the VWF gene itself, implicating mutations in other genes.
Abstract:
Von Willebrand disease (VWD) is classified into three primary subtypes; type 1 includes partial quantitative deficiency, type 2 (A, B, M and N) includes qualitative defects and type 3 includes virtually complete deficiency of von Willebrand factor (VWF). Type 2A includes variants with decreased platelet adhesion caused by selective deficiency of high molecular weight VWF multimers. Type 2B includes variants with increased affinity for platelet glycoprotein Ib. Type 2M includes variants with markedly defective platelet adhesion despite normal sized VWF multimers. Finally, type 2N includes variants with markedly decreased affinity for factor VIII (FVIII). Studies have begun to address the association between particular genetic variants of VWF and the disease phenotype. For example, the recessive type 3 disease appears to be due to a variety of mutations that result in a null phenotype, while type 2N disease results from a group of recessive missense mutations that interfere with FVIII binding. Recently, the molecular pathogenesis of type 1 VWD has begun to be characterised revealing a diverse spectrum of genetic changes. In two large studies, patients with type 1 VWD were found to be heterozygous for a variety of missense, splice site and transcriptional mutations. In some patients, more than one variant sequence was present, and in a significant number of individuals no changes were evident in the VWF gene. These results suggest that the molecular correlates for type 1 VWD are complex and, in addition to a wide array of changes at the VWF locus, are likely to involve mutations in other genes.
Related Concept Videos
Pleiotropy
Incomplete Dominance
Pedigree Analysis
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic Lingo
Multiple Allele Traits
